Lineage Cell Therapeutics
LCTX
#8789
Rank
NZ$0.23 B
Marketcap
$1.05
Share price
2.80%
Change (1 day)
-40.39%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$36.91 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$8.71 Million. In 2023 the company made an earning of -NZ$44.29 Million a decrease over its 2022 earnings that were of -NZ$40.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$36.91 Million-16.68%
2023 -NZ$44.29 Million9.83%
2022 -NZ$40.33 Million-54.24%
2021 -NZ$88.13 Million86.07%
2020 -NZ$47.36 Million-31.97%
2019 -NZ$69.62 Million-5.42%
2018 -NZ$73.61 Million1.1%
2017 -NZ$72.81 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$90.86 Million31.68%
2013 -NZ$69.01 Million
2011 -NZ$33.49 Million89.78%
2010 -NZ$17.65 Million206.06%
2009 -NZ$5.77 Million-0.58%
2008 -NZ$5.8 Million164.89%
2007 -NZ$2.19 Million-30.22%
2006 -NZ$3.14 Million
2002 -NZ$3.65 Million-41.04%
2001 -NZ$6.18 Million-32.04%
2000 -NZ$9.1 Million-11.85%
1999 -NZ$10.32 Million
1997 -NZ$6.63 Million12.12%
1996 -NZ$5.91 Million106.25%
1995 -NZ$2.87 Million-11.11%
1994 -NZ$3.23 Million50%
1993 -NZ$2.15 Million20%
1992 -NZ$1.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.25 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA